Table 1.
Patient Demographics and Prostate-Related Findings
| Site | 1 | 2 | 3 | 4 | 5 | All | |
|---|---|---|---|---|---|---|---|
| Patients, N | 29 | 19 | 18 | 26 | 46 | 138 | |
| Age, yrs | Mean (SD) | 60.38 (9.41) | 65.87 (8.3) | 59.94 (7.77) | 59.12 (10.14) | 63.48 (7.73) | 61.7 (8.9) |
| Median (range) | 59 (40–75) | 67 (52–82) | 60 (43–70) | 61 (44–78) | 65 (44–77) | 63 (40–82) | |
| ≥65 (%) | 11 (38) | 9 (60) | 5 (31) | 10 (38) | 22 (55) | 57 (45) | |
| PSA at biopsy, ng/mL | Mean (SD) | 5.82 (6.81) | 6.69 (6.29) | 4.53 (2.23) | 8.16 (15.31) | 5.02 (3.25) | 5.95 (7.95) |
| Median (range) | 4.85 (0.2–37.5) | 5.52 (0.78–30.4) | 4.47 (0.5–11.8) | 4.7 (0.4–81) | 4.37 (0.33–16.6) | 4.7 (0.2–81) | |
| Current PSA, ng/mL | Mean (SD) | 4.25 (5.14) | 6.4 (6.02) | 3.7 (2.08) | 8.6 (14.37) | 6.02 (6.82) | 6.03 (8.45) |
| Median (range) | 3.1 (0.2–24.5) | 4.43 (2.17–25.5) | 3.7 (0.5–7.3) | 5.1 (0.59–75.2) | 4.6 (0.33–42.91) | 4.43 (0.2–75.2) | |
| DRE | Normal, N (%) | 17 (63) | 19 (100) | 13 (72) | 19 (73) | 34 (74) | 102 (75) |
| Abnormal, N (%) | 10 (37) | 0 (0) | 5 (28) | 7 (27) | 12 (26) | 34 (25) | |
| Histopathology | Normal, N | 28 | 15 | 18 | 26 | 46 | 133 |
| Abnormal, N (%) | 1 (3.5) | 4 (21) | 0 (0) | 0 (0) | 0 (0) | 5 (3.7) | |
| Repeated biopsy? | No | 27 | 19 | 17 | 24 | 45 | 132 |
| Yes, N (%) | 2 (6.9) | 0 (0) | 1 (5.6) | 2 (7.7) | 1 (2.2) | 6 (4.3) | |
| Negative, N | 2 | 0 | 1 | 1 | 1 | 6 | |
| Positive, N | 0 | 0 | 0 | 0 | 0 | 0 | |
DRE indicates digital rectal examination; PSA, prostate-specific antigen; SD, standard deviation.